| |
Step change [95% Wald CI]
|
|
Odds of being reimbursed for an analgesic or NSAID, in intervention compared to control group (PO1)
|
0.9973 [0.9860; 1.0088]
|
0.9929 [0.9780; 1.0081]
|
1.0218 [0.9982; 1.0459]
|
|
Average defined daily dose of paracetamol per patient reimbursed for paracetamol per month, in intervention compared to control group (PO2)
|
− 0.3106 [− 0.8493; 0.2281]
|
− 0.2442 [− 0.8677; 0.3793]
|
− 0.2665 [− 0.8491; 0.3161]
|
|
Odds of being reimbursed for a recommended NSAID when reimbursed for any NSAID, in intervention compared to control group (PO3)
|
1.1887* [1.1004; 1.2841]
|
1.2158* [1.1276; 1.3109]
|
1.2158* [1.1276; 1.3109]
|
|
Odds of being reimbursed for an NSAID and a PPI when reimbursed for an NSAID, in intervention compared to control group (PO4)
|
1.0194 [0.9419; 1.1032]
|
1.0188 [0.9336; 1.1117]
|
1.0050 [0.9534; 1.0593]
|
| |
Change in trend [95% Wald CI]
|
|
Odds of being reimbursed for an analgesic or NSAID, in intervention compared to control group (PO1)
|
0.9882* [0.9790; 0.9975]
|
0.9896* [0.9806; 0.9987]
|
0.9990 [0.9945; 1.0035]
|
|
Average defined daily dose of paracetamol per patient reimbursed for paracetamol per month, in intervention compared to control group (PO2)
|
0.0389 [− 0.1446; 0.2224]
|
0.0937 [− 0.0686; 0.2560]
|
0.1400 [− 0.0513; 0.3313]
|
|
Odds of being reimbursed for a recommended NSAID when reimbursed for any NSAID, in intervention compared to control group (PO3)
|
0.9902 [0.9775; 1.0030]
|
0.9894 [0.9776; 1.0013]
|
0.9882 [0.9753; 1.0012]
|
|
Odds of being reimbursed for an NSAID and a PPI when reimbursed for an NSAID, in intervention compared to control group (PO4)
|
0.9940 [0.9765; 1.0118]
|
0.9944 [0.9762; 1.0129]
|
0.9968 [0.9770; 1.0170]
|
